Facebook Linkedin Twitter
Inside Precision Medicine TriLink Cuts Ribbon to mRNA Production Facility for Medical Countermeasures

Phase I clinical trials (Clinical trial)

Single strand ribonucleic acid, RNA research
Coronavirus

TriLink Cuts Ribbon to mRNA Production Facility for Medical Countermeasures

Jonathan D. Grinstein, PhD
0
Hodgkin lymphoma, light micrograph
News & Features

CAR-T Targeting CD22 Delivers Positive Early Results in Lymphoma 

0
Conceptual image for viral ethiology of prostate cancer
News & Features

Prostate Cancer CAR T Treatment Shows Promising Therapeutic Activity

0
T-Cell Attacks Cancer Cell
Informatics

GoldenEye: KSQ Doses First Solid Tumor Patient with CRISPR/Cas9 eTILs

Jonathan D. Grinstein, PhD
0
Illustration of human kidneys in blue, surrounded by red cancer cells to illustrate renal cell carcinoma before treatment with allogeneic CAR T-cell therapy.
Molecular Dx

Phase I Win for Kidney Disease Drug in Subtype Common to People of African Descent 

0
Nerve cells affected by Alzheimer's disease, illustration
News & Features

Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine

0
Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).
News & Features

Verve Starts Second Human Cardiovascular Gene Therapy Trial

0
Brain Tumor
News & Features

mRNA Cancer Vaccine Reprograms Immune System to Tackle Glioblastoma

0
Sarcoma cells
News & Features

CAR T-Cell Therapy for Sarcoma Shows Early Promise

0
Sarcoma cells
News & Features

Next-Generation T Cell Therapy Shows Promise For Solid Tumors

Laura Cowen
0
1234Page 1 of 4

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine